CA2010588A1 - Derives de pyrimidine substitues, procede de preparation, et leur utilization - Google Patents

Derives de pyrimidine substitues, procede de preparation, et leur utilization

Info

Publication number
CA2010588A1
CA2010588A1 CA2010588A CA2010588A CA2010588A1 CA 2010588 A1 CA2010588 A1 CA 2010588A1 CA 2010588 A CA2010588 A CA 2010588A CA 2010588 A CA2010588 A CA 2010588A CA 2010588 A1 CA2010588 A1 CA 2010588A1
Authority
CA
Canada
Prior art keywords
preparation
pyrimidine derivatives
substituted pyrimidine
sorbitol
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2010588A
Other languages
English (en)
Other versions
CA2010588C (fr
Inventor
Karl Geisen
Hans-Jochen Lang
Hildegard Nimmesgern
Klaus Weidmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of CA2010588A1 publication Critical patent/CA2010588A1/fr
Application granted granted Critical
Publication of CA2010588C publication Critical patent/CA2010588C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
CA002010588A 1989-02-22 1990-02-21 Derives de pyrimidine substitues, procede de preparation, et leur utilization Expired - Lifetime CA2010588C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3905364A DE3905364A1 (de) 1989-02-22 1989-02-22 Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
DEP3905364.4 1989-02-22

Publications (2)

Publication Number Publication Date
CA2010588A1 true CA2010588A1 (fr) 1990-08-22
CA2010588C CA2010588C (fr) 2000-01-18

Family

ID=6374628

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002010588A Expired - Lifetime CA2010588C (fr) 1989-02-22 1990-02-21 Derives de pyrimidine substitues, procede de preparation, et leur utilization

Country Status (18)

Country Link
US (1) US5138058A (fr)
EP (1) EP0384370B1 (fr)
JP (1) JP2955318B2 (fr)
KR (1) KR0142189B1 (fr)
AT (1) ATE96787T1 (fr)
AU (1) AU634751B2 (fr)
CA (1) CA2010588C (fr)
DE (2) DE3905364A1 (fr)
DK (1) DK0384370T3 (fr)
ES (1) ES2060829T3 (fr)
FI (1) FI95694C (fr)
IE (1) IE63570B1 (fr)
IL (1) IL93465A (fr)
NO (1) NO178431C (fr)
NZ (1) NZ232601A (fr)
PH (1) PH27222A (fr)
PT (1) PT93224B (fr)
ZA (1) ZA901309B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU768720B2 (en) * 1999-04-01 2004-01-08 Pfizer Products Inc. Aminopyrimidines as sorbitol dehydrogenase inhibitors

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662607B1 (fr) * 1990-05-30 1992-08-28 Oreal Composition destinee a etre utilisee pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives d'alkyl-2 amino-4 (ou dialkyl-2-4) pyrimidine oxyde-3 .
DE4025387A1 (de) * 1990-08-10 1992-02-13 Hoechst Ag Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als reagenzien
DE4142191A1 (de) * 1991-12-20 1993-06-24 Bayer Ag Verfahren zur herstellung von 3-alkoxy-acrylestern
ATE178056T1 (de) * 1992-04-28 1999-04-15 Yamanouchi Pharma Co Ltd Substituierte tertiäre amine und deren salze
AU683620B2 (en) * 1992-09-28 1997-11-20 Pfizer Inc. Substituted pyrimidines for control of diabetic complications
IL115420A0 (en) 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
GB9602166D0 (en) * 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
US6313127B1 (en) 1996-02-02 2001-11-06 Zeneca Limited Heterocyclic compounds useful as pharmaceutical agents
EP0791355B1 (fr) * 1996-02-29 2002-04-17 Pfizer Inc. Utilisation d'inhibiteurs de deshydrogenase de sorbitol pour reduire des lésions tissulaires associés avec l'ischemie
JPH09301868A (ja) * 1996-05-10 1997-11-25 Senju Pharmaceut Co Ltd 抗白内障剤
BR9711135A (pt) * 1996-08-14 1999-08-17 Zeneca Ltd Composto composi-Æo farmac-utica utiliza-Æo de um composto e processos para prepara-Æo de um composto e para inibi-Æo de Äxido-equaleno ciclase num animal de sangue quente requerendo um tal tratamento
WO1998014430A1 (fr) * 1996-10-02 1998-04-09 Sumitomo Pharmaceuticals Co., Ltd. Derives de pyrimidine
UA56197C2 (uk) 1996-11-08 2003-05-15 Зенека Лімітед Гетероциклічні похідні
US6440972B1 (en) 1997-02-13 2002-08-27 Zeneca Limited Heterocyclic compounds useful as oxido-squalene cyclase inhibitors
DK0966462T3 (da) 1997-02-13 2003-09-22 Astrazeneca Ab Heterocykliske forbindelser, der er egnede som oxidosqualencyklaseinhibitorer
DE19710435A1 (de) * 1997-03-13 1998-09-17 Hoechst Ag Verwendung von Pyrimidinderivaten zur Prävention von Krebs allein oder in Kombination mit anderen therapeutischen Maßnahmen
GB9715895D0 (en) 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
GB9902989D0 (en) 1999-02-11 1999-03-31 Zeneca Ltd Heterocyclic derivatives
DE60009777T2 (de) * 1999-04-01 2004-08-19 Pfizer Products Inc., Groton Verbindung für Behandlung und Vorsorge bei Diabetes
IL154240A0 (en) * 2000-08-08 2003-07-31 Ortho Mcneil Pharm Inc 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods
DE60108164T2 (de) 2000-11-02 2006-03-02 F. Hoffmann-La Roche Ag Cholesterin senkende Benzo[b]thiophene und Benzo[d]isothiazole
US6503907B2 (en) 2000-11-28 2003-01-07 Hoffmann-La Roche Inc. Indole and dihydroindole derivatives
EP1247809A3 (fr) * 2001-03-30 2003-12-17 Pfizer Products Inc. Dérivés de triazine et leur application comme inhibiteurs de sorbitol-déhydrogénase
US6825198B2 (en) * 2001-06-21 2004-11-30 Pfizer Inc 5-HT receptor ligands and uses thereof
US20040082627A1 (en) * 2002-06-21 2004-04-29 Darrow James W. Certain aromatic monocycles as kinase modulators
US7015227B2 (en) * 2002-06-21 2006-03-21 Cgi Pharmaceuticals, Inc. Certain amino-substituted monocycles as kinase modulators
GB0323137D0 (en) * 2003-10-03 2003-11-05 Chang Lisa C W 2,4,6- Trisubstituted pyrimidines and their different uses
US7434592B2 (en) * 2003-10-10 2008-10-14 Millennial Medical Equipment, L.L.C. Ergonomic collapsible crutch
US7104271B2 (en) * 2003-10-10 2006-09-12 Millennial Medical Equipment, L.L.C. Ergonomic collapsible crutch
US20080058356A1 (en) * 2003-12-15 2008-03-06 Neurocrine Biosciences, Inc. 2,6 Bisheteroaryl-4-Aminopyrimidines as Adenosine Receptor Antagonists
TWI355894B (en) * 2003-12-19 2012-01-11 Du Pont Herbicidal pyrimidines
EP1888565B1 (fr) * 2005-04-11 2011-03-23 Almirall, S.A. 2,6-di-(hétéro)aryl-4-amido-pyrimidines utiles comme antagonistes des récepteurs de l'adénosine
WO2007070506A2 (fr) * 2005-12-14 2007-06-21 Amgen Inc. Derives diaza heterocycliques de sulfonamide et leurs utilisations
WO2008070661A1 (fr) * 2006-12-04 2008-06-12 Neurocrine Biosciences, Inc. Pyrimidines substituées en tant qu'antagonistes des récepteurs de l'adénosine
EP3012249A1 (fr) 2006-12-08 2016-04-27 Novartis AG Composes et compostions inhibtant la proteine kinase
US20100249084A1 (en) * 2007-03-21 2010-09-30 Youngsheng Chen Substituted pyrimidines as adenosine receptor antagonists
CA2833209C (fr) 2007-04-27 2016-06-28 Purdue Pharma L.P. Composes de piperidine et piperazine en tant qu'antagonistes de trpv1
AR086709A1 (es) 2011-06-22 2014-01-15 Purdue Pharma Lp Antagonistas trpv1 que incluyen sustituyentes dihidroxi y sus usos
CN102675217A (zh) * 2012-05-24 2012-09-19 盛世泰科生物医药技术(苏州)有限公司 一种5-溴-2-甲基-4(1h)-嘧啶酮的制备方法
CN110372602A (zh) * 2019-06-24 2019-10-25 南京普锐达医药科技有限公司 一种4-氯-2-甲基嘧啶的合成方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB959699A (en) * 1961-06-09 1964-06-03 May & Baker Ltd New pyrimidine derivatives
GB1143167A (en) * 1967-01-25 1969-02-19 Ucb Sa Derivatives of pyrimidine
US3707560A (en) * 1970-10-05 1972-12-26 Pfizer Certain 4-amino-6-aryl-pyrimidines
US3859288A (en) * 1970-10-05 1975-01-07 Pfizer Arylpyrimidines - inhibitors of platelet aggregation and bronchodilators
JPS5031157B1 (fr) * 1970-10-22 1975-10-07
NL7103449A (fr) * 1971-03-15 1972-09-19
DE2263052A1 (de) * 1972-12-22 1974-07-04 Wacker Chemie Gmbh Neue pyrimidine
CH595061A5 (fr) * 1974-05-10 1978-01-31 Ciba Geigy Ag
DE2433176C3 (de) * 1974-07-10 1979-06-07 Daiichi Seiyaku Co., Ltd., Tokio N-Cyano-cyano-acetimidate und Verfahren zur Herstellung von 2-Halopyrinüdinderivaten
US4191553A (en) 1978-03-02 1980-03-04 E. I. Du Pont De Nemours And Company Herbicidal sulfamates
CH643583A5 (de) * 1979-08-16 1984-06-15 Sandoz Ag Reaktivfarbstoffe sowie deren herstellung.
US4323681A (en) * 1980-09-29 1982-04-06 American Home Products Corporation 4-Amino-2-substituted-5-pyrimidinecarboxamidoximes and carbothioamides
LU86695A1 (fr) * 1986-12-01 1988-07-14 Oreal Nouveaux derives de piperazinyl-1 pyrimidine,leur preparation et leur application en therapeutique et cosmetique
US4900813A (en) * 1987-07-02 1990-02-13 Ciba-Geigy Corporation Fiber-reactive azo dyes having a 4,6-diaminopyridine coupling component
US4931455A (en) * 1988-01-07 1990-06-05 Ube Industries, Ltd. Alkylaminopyrimidine derivative and insecticide, acaricide and fungicide containing the same as active ingredient
EP0330263A1 (fr) * 1988-02-25 1989-08-30 Merck & Co. Inc. Pipérazinylalkylpyrimidines comme agents hypoglycémiques

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU768720B2 (en) * 1999-04-01 2004-01-08 Pfizer Products Inc. Aminopyrimidines as sorbitol dehydrogenase inhibitors

Also Published As

Publication number Publication date
PH27222A (en) 1993-05-04
NO900822L (no) 1990-08-23
NO900822D0 (no) 1990-02-21
EP0384370A1 (fr) 1990-08-29
EP0384370B1 (fr) 1993-11-03
DE59003274D1 (de) 1993-12-09
US5138058A (en) 1992-08-11
FI95694C (fi) 1996-03-11
AU4997590A (en) 1990-08-30
ZA901309B (en) 1990-10-31
NZ232601A (en) 1991-12-23
IE63570B1 (en) 1995-05-17
CA2010588C (fr) 2000-01-18
IL93465A0 (en) 1990-11-29
ES2060829T3 (es) 1994-12-01
FI900839A0 (fi) 1990-02-20
JP2955318B2 (ja) 1999-10-04
AU634751B2 (en) 1993-03-04
JPH02255662A (ja) 1990-10-16
PT93224A (pt) 1990-08-31
NO178431C (no) 1996-03-27
IL93465A (en) 1995-03-30
FI95694B (fi) 1995-11-30
KR0142189B1 (ko) 1998-06-01
IE900627L (en) 1990-08-22
ATE96787T1 (de) 1993-11-15
NO178431B (no) 1995-12-18
DE3905364A1 (de) 1990-08-23
PT93224B (pt) 1996-09-30
KR900012916A (ko) 1990-09-03
DK0384370T3 (da) 1994-03-07

Similar Documents

Publication Publication Date Title
CA2010588A1 (fr) Derives de pyrimidine substitues, procede de preparation, et leur utilization
AU583055B2 (en) Tetralin derivatives, their preparation and their use
PL295030A1 (en) Method of obtaining substituted derivatives of 2-cyclohexan-1-yl amine
CA2011329A1 (fr) Derives de xanthine
AU582124B2 (en) Cyclohexenol derivatives and their use for controlling undersirable plant growth
AU8256191A (en) Substituted pyrimidine derivatives, a process for the preparation thereof and the use thereof as reagents
DE3167320D1 (en) Novel uracil derivatives, process for preparing the same and a pharmaceutical composition containing the same
PL288409A1 (en) Method of obtaining novel derivatives of 4-phenyl-4-piperidinecarboxyamide
AU5111893A (en) Process for obtaining benzoxazines useful for the synthesis of ofloxacin, levofloxacin and derivatives thereof
AU3420099A (en) Process for the production of purine derivatives and intermediates therefor
RU94003397A (ru) Производные 2-/4-(4-азолилбутил)-1-пиперазинил/-пиримидина, способ их получения и фармацевтическая композиция на их основе
AU3259997A (en) Ring-fused dihydropyranes, process for the preparation and use thereof
CA2120229A1 (fr) Derives de methylpiperazinoazepine, leur preparation et leur utilisation
GR900100069A (en) Method for producing phenylosulphone derivatives
HU9600300D0 (en) Thiocarbamoyl derivatives using as antimicrobial agents and process for producing of these
CA2044796A1 (fr) Procede de production d'un derive de pyrido [1,2-a] pyrimidine
IT1254201B (it) Procedimento per la preparazione di derivati del glicerolo otticamente attivi.
ES2103166A1 (es) Procedimiento para la obtencion de amidinohidrazonas biciclicas.
MX9706968A (es) Compuesto de tiocarbamoilo.

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry